How EMPClaims Reduced Rheumatology Claim Denials by 50%

The Problem Wasn’t the Billing. It Was the Pattern.

When EMPClaims began auditing the practice’s revenue operations, the surface-level data told one story: a high denial rate on specialty procedures. But the underlying cause was more specific.

Payers remember patterns. When the same CPT codes are billed repeatedly — as they must be in rheumatology — any inconsistency in coding, authorization status, or documentation creates a repeating target. Payers don’t just deny a single claim. They build a behavioral profile.

What our team found across this practice’s locations:

• Authorizations expiring mid-treatment. Infliximab and other biologic infusions require authorization continuity across visits. Gaps weren’t being caught before claims went out.
• Coding inconsistencies across repeat encounters. When the same service is billed differently visit-to-visit, payers flag it — and the flags stack.
• Medical necessity reviews stalling AR. Claims weren’t failing on technical grounds; they were getting pulled into review cycles with no structured follow-up process.
• Credentialing gaps delaying reimbursement. Across multiple locations, provider enrollment wasn’t current with all active payers.

None of these were billing mistakes in the traditional sense. They were process failures — structural gaps that grew more expensive with every month they went unaddressed.

What EMPClaims Changed

Authorization Discipline Became a Workflow, Not a Reminder

The first intervention was rebuilding how the practice tracked prior authorizations across its locations. EMPClaims implemented structured authorization lifecycle management: approvals obtained before service, approval limits tracked visit-to-visit, and expiring or missing authorizations surfaced before claims were submitted.

For a practice billing infusion services and specialty biologics, this alone eliminated a significant category of preventable denials.

Coding Consistency Across Providers and Visits

Our certified coders reviewed the practice’s CPT patterns across providers and encounter types. The goal wasn’t just accuracy on any given claim — it was eliminating the variation that gives payers a reason to scrutinize.

For rheumatology, where the same patient returns for the same treatment across dozens of visits per year, coding consistency is a revenue protection strategy, not a compliance checkbox.

Denial Root-Cause Tracking and Structured AR Follow-Up

EMPClaims introduced payer-specific AR workflows with structured denial analysis. Instead of chasing each denied claim individually, the team identified which denial categories were repeating — and traced them back to their source. Front-end corrections followed.

Credentialing Remediation Across Locations

Active providers were audited against payer enrollment records. Credentialing gaps were closed and ongoing re-credentialing was incorporated into standard operations, preventing the enrollment lapses that silently block reimbursement at multi-location practices.

The Results

Within the engagement period, the practice’s denial rate dropped from 40% to 20–25% — a reduction of approximately 50%.

What This Means for Rheumatology Practices

A 50% reduction in denial rate doesn’t happen because you bill harder. It happens because you change the underlying conditions that produce denials.

For rheumatology specifically, that means:

• Authorization tracking that matches your treatment cycles, not a generic prior auth checklist
• Coding that accounts for the longitudinal nature of rheumatology care
• AR management that identifies patterns, not just individual claim failures
• Credentialing oversight that keeps up with provider movement across locations

Rheumatology revenue is built on consistency and discipline — not speed.